{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:52:39Z","timestamp":1768647159389,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T00:00:00Z","timestamp":1438992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00702-015-1438-9","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T15:20:22Z","timestamp":1438960822000},"page":"1645-1657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system"],"prefix":"10.1007","volume":"122","author":[{"given":"Qian","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suosuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,8]]},"reference":[{"issue":"Pt 12","key":"1438_CR1","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","volume":"128","author":"JR Adams","year":"2005","unstructured":"Adams JR, van Netten H, Schulzer M, Mak E, McKenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation. Brain 128(Pt 12):2777\u20132785. doi: 10.1093\/brain\/awh607","journal-title":"Brain"},{"issue":"4","key":"1438_CR2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuroscience.2009.04.031","volume":"161","author":"ZC Baquet","year":"2009","unstructured":"Baquet ZC, Williams D, Brody J, Smeyne RJ (2009) A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL\/6J mouse. Neuroscience 161(4):1082\u20131090. doi: 10.1016\/j.neuroscience.2009.04.031","journal-title":"Neuroscience"},{"key":"1438_CR3","first-page":"301","volume":"8","author":"DA Beccano-Kelly","year":"2014","unstructured":"Beccano-Kelly DA, Kuhlmann N, Tatarnikov I, Volta M, Munsie LN, Chou P, Cao LP, Han H, Tapia L, Farrer MJ, Milnerwood AJ (2014) Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front Cell Neurosci 8:301. doi: 10.3389\/fncel.2014.00301","journal-title":"Front Cell Neurosci"},{"issue":"33","key":"1438_CR4","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","volume":"28","author":"L Bedford","year":"2008","unstructured":"Bedford L, Hay D, Devoy A, Paine S, Powe DG, Seth R, Gray T, Topham I, Fone K, Rezvani N, Mee M, Soane T, Layfield R, Sheppard PW, Ebendal T, Usoskin D, Lowe J, Mayer RJ (2008) Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 28(33):8189\u20138198. doi: 10.1523\/jneurosci.2218-08.2008","journal-title":"J Neurosci"},{"issue":"5","key":"1438_CR5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1042\/BST20120124","volume":"40","author":"E Belluzzi","year":"2012","unstructured":"Belluzzi E, Greggio E, Piccoli G (2012) Presynaptic dysfunction in Parkinson\u2019s disease: a focus on LRRK2. Biochem Soc Trans 40(5):1111\u20131116. doi: 10.1042\/bst20120124","journal-title":"Biochem Soc Trans"},{"issue":"Suppl 1","key":"1438_CR6","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1353-8020(13)70009-9","volume":"20","author":"V Bonifati","year":"2014","unstructured":"Bonifati V (2014) Genetics of Parkinson\u2019s disease\u2013state of the art, 2013. Parkinsonism Relat Disord 20(Suppl 1):S23\u2013S28. doi: 10.1016\/s1353-8020(13)70009-9","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1438_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.22588","volume":"71","author":"AS Buchman","year":"2012","unstructured":"Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA (2012) Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol 71(2):258\u2013266. doi: 10.1002\/ana.22588","journal-title":"Ann Neurol"},{"key":"1438_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2012.06.025","volume":"57","author":"JR Cannon","year":"2013","unstructured":"Cannon JR, Greenamyre JT (2013) Gene-environment interactions in Parkinson\u2019s disease: specific evidence in humans and mammalian models. Neurobiol Dis 57:38\u201346. doi: 10.1016\/j.nbd.2012.06.025","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1438_CR9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jnr.23242","volume":"91","author":"JM Crain","year":"2013","unstructured":"Crain JM, Nikodemova M, Watters JJ (2013) Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 91(9):1143\u20131151. doi: 10.1002\/jnr.23242","journal-title":"J Neurosci Res"},{"issue":"5","key":"1438_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2011.11.025","volume":"18","author":"O Darbin","year":"2012","unstructured":"Darbin O (2012) The aging striatal dopamine function. Parkinsonism Relat Disord 18(5):426\u2013432. doi: 10.1016\/j.parkreldis.2011.11.025","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1438_CR11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909. doi: 10.1016\/S0896-6273(03)00568-3","journal-title":"Neuron"},{"issue":"6","key":"1438_CR12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. doi: 10.1016\/s1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"3","key":"1438_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51(3):296\u2013301. doi: 10.1002\/ana.10113","journal-title":"Ann Neurol"},{"issue":"9457","key":"1438_CR14","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet 365(9457):415\u2013416. doi: 10.1016\/s0140-6736(05)17830-1","journal-title":"Lancet"},{"key":"1438_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuropharm.2014.05.020","volume":"85","author":"P Gomez-Suaga","year":"2014","unstructured":"Gomez-Suaga P, Fdez E, Fernandez B, Martinez-Salvador M, Blanca Ramirez M, Madero-Perez J, Rivero-Rios P, Fuentes JM, Hilfiker S (2014) Novel insights into the neurobiology underlying LRRK2-linked Parkinson\u2019s disease. Neuropharmacology 85:45\u201356. doi: 10.1016\/j.neuropharm.2014.05.020","journal-title":"Neuropharmacology"},{"issue":"3","key":"1438_CR16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1471-4159.2003.02017.x","volume":"87","author":"JW Haycock","year":"2003","unstructured":"Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ (2003) Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87(3):574\u2013585. doi: 10.1046\/j.1471-4159.2003.02017.x","journal-title":"J Neurochem"},{"issue":"7","key":"1438_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7(7):583\u2013590. doi: 10.1016\/s1474-4422(08)70117-0","journal-title":"Lancet Neurol"},{"issue":"3","key":"1438_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","volume":"84","author":"GU Hoglinger","year":"2003","unstructured":"Hoglinger GU, Feger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH, Hirsch EC (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84(3):491\u2013502. doi: 10.1046\/j.1471-4159.2003.01533.x","journal-title":"J Neurochem"},{"key":"1438_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-211-45295-0_41","volume":"70","author":"GU Hoglinger","year":"2006","unstructured":"Hoglinger GU, Oertel WH, Hirsch EC (2006) The rotenone model of parkinsonism\u2013the five years inspection. J Neural Transm Suppl 70:269\u2013272. doi: 10.1007\/978-3-211-45295-0_41","journal-title":"J Neural Transm Suppl"},{"issue":"10\u201311","key":"1438_CR20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"K Jellinger","year":"2004","unstructured":"Jellinger K (2004) Lewy body-related \u03b1-synucleinopathy in the aged human brain. J Neural Transm 111(10\u201311):1219\u20131235. doi: 10.1007\/s00702-004-0138-7","journal-title":"J Neural Transm"},{"issue":"7","key":"1438_CR21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0149-7634(02)00065-9","volume":"26","author":"V Kaasinen","year":"2002","unstructured":"Kaasinen V, Rinne JO (2002) Functional imaging studies of dopamine system and cognition in normal aging and Parkinson\u2019s disease. Neurosci Biobehav Rev 26(7):785\u2013793. doi: 10.1016\/S0149-7634(02)00065-9","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1438_CR22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","volume":"18","author":"N Lapointe","year":"2004","unstructured":"Lapointe N, St-Hilaire M, Martinoli MG, Blanchet J, Gould P, Rouillard C, Cicchetti F (2004) Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J 18(6):717\u2013719. doi: 10.1096\/fj.03-0677fje","journal-title":"FASEB J"},{"issue":"1","key":"1438_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-013-0234-1","volume":"11","author":"W Le","year":"2014","unstructured":"Le W, Sayana P, Jankovic J (2014) Animal models of Parkinson\u2019s disease: a gateway to therapeutics? Neurotherapeutics 11(1):92\u2013110. doi: 10.1007\/s13311-013-0234-1","journal-title":"Neurotherapeutics"},{"issue":"5","key":"1438_CR24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1042\/BST20120113","volume":"40","author":"S Lee","year":"2012","unstructured":"Lee S, Imai Y, Gehrke S, Liu S, Lu B (2012) The synaptic function of LRRK2. Biochem Soc Trans 40(5):1047\u20131051. doi: 10.1042\/bst20120113","journal-title":"Biochem Soc Trans"},{"issue":"7\u20138","key":"1438_CR25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.neuint.2007.04.014","volume":"50","author":"X Li","year":"2007","unstructured":"Li X, Yang D, Li L, Peng C, Chen S, Le W (2007) Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures. Neurochem Int 50(7\u20138):959\u2013965. doi: 10.1016\/j.neuint.2007.04.014","journal-title":"Neurochem Int"},{"issue":"10","key":"1438_CR26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","volume":"67","author":"X Li","year":"2008","unstructured":"Li X, Du Y, Fan X, Yang D, Luo G, Le W (2008) c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration. J Neuropathol Exp Neurol 67(10):933\u2013944. doi: 10.1097\/nen.0b013e318186de64","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1438_CR27","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","volume":"30","author":"X Li","year":"2010","unstructured":"Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, Buxbaum JD, Elder GA, Rice ME, Yue Z (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson\u2019s disease mutation G2019S. J Neurosci 30(5):1788\u20131797. doi: 10.1523\/jneurosci.5604-09.2010","journal-title":"J Neurosci"},{"issue":"6","key":"1438_CR28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.neuron.2012.08.022","volume":"75","author":"S Matta","year":"2012","unstructured":"Matta S, Van Kolen K, da Cunha R, van den Bogaart G, Mandemakers W, Miskiewicz K, De Bock P-J, Morais VA, Vilain S, Haddad D (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 75(6):1008\u20131021. doi: 10.1016\/j.neuron.2012.08.022","journal-title":"Neuron"},{"issue":"17","key":"1438_CR29","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1089\/ars.2013.5802","volume":"21","author":"C McKinnon","year":"2014","unstructured":"McKinnon C, Tabrizi SJ (2014) The ubiquitin-proteasome system in neurodegeneration. Antioxid Redox Signal 21(17):2302\u20132321. doi: 10.1089\/ars.2013.5802","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"1438_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease. Neurosci Lett 297(3):191\u2013194. doi: 10.1016\/S0304-3940(00)01701-8","journal-title":"Neurosci Lett"},{"issue":"8","key":"1438_CR31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35086067","volume":"2","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin-proteasome system in Parkinson\u2019s disease. Nat Rev Neurosci 2(8):589\u2013594. doi: 10.1038\/35086067","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1438_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179(1):38\u201346. doi: 10.1006\/exnr.2002.8050","journal-title":"Exp Neurol"},{"issue":"1","key":"1438_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 56(1):149\u2013162. doi: 10.1002\/ana.20186","journal-title":"Ann Neurol"},{"issue":"22","key":"1438_CR34","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1212\/01.wnl.0000335973.66333.58","volume":"71","author":"R Nandhagopal","year":"2008","unstructured":"Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ (2008) Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 71(22):1790\u20131795. doi: 10.1212\/01.wnl.0000335973.66333.58","journal-title":"Neurology"},{"issue":"9457","key":"1438_CR35","first-page":"410","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease. Lancet 365(9457):410\u2013412. doi: 10.1016\/s0140-6736(05)17828-3","journal-title":"Lancet"},{"issue":"4","key":"1438_CR36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44(4):595\u2013600. doi: 10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"1438_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K","volume":"384","author":"B Pakkenberg","year":"1997","unstructured":"Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384:312\u2013320. doi: 10.1002\/(sici)1096-9861(19970728)384:2<312:aid-cne10>3.3.co;2-g","journal-title":"J Comp Neurol"},{"issue":"1","key":"1438_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2008.06.003","volume":"32","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W (2008) Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32(1):16\u201325. doi: 10.1016\/j.nbd.2008.06.003","journal-title":"Neurobiol Dis"},{"key":"1438_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D (2014) Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev 14:19\u201330. doi: 10.1016\/j.arr.2014.01.004","journal-title":"Ageing Res Rev"},{"issue":"2","key":"1438_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(90)90423-9","volume":"508","author":"JO Rinne","year":"1990","unstructured":"Rinne JO, L\u00f6nnberg P, Marjam\u00e4ki P (1990) Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res 508(2):349\u2013352. doi: 10.1016\/0006-8993(90)90423-9","journal-title":"Brain Res"},{"issue":"4","key":"1438_CR41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-008-0352-8","volume":"115","author":"G Rudow","year":"2008","unstructured":"Rudow G, O\u2019Brien R, Savonenko AV, Resnick SM, Zonderman AB, Pletnikova O, Marsh L, Dawson TM, Crain BJ, West MJ (2008) Morphometry of the human substantia nigra in ageing and Parkinson\u2019s disease. Acta Neuropathol 115(4):461\u2013470. doi: 10.1007\/s00401-008-0352-8","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1438_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mdc3.12000","volume":"1","author":"UM Sheerin","year":"2014","unstructured":"Sheerin UM, Houlden H, Wood NW (2014) Advances in the genetics of Parkinson\u2019s disease: a guide for the clinician. Mov Disord Clin Pract 1(1):3\u201313. doi: 10.1002\/mdc3.12000","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"1438_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2013.159","volume":"21","author":"Y Tang","year":"2014","unstructured":"Tang Y, Li T, Li J, Yang J, Liu H, Zhang XJ, Le W (2014) Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson\u2019s disease. Cell Death Differ 21(3):369\u2013380. doi: 10.1038\/cdd.2013.159","journal-title":"Cell Death Differ"},{"issue":"3","key":"1438_CR44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","volume":"31","author":"A Verstraeten","year":"2015","unstructured":"Verstraeten A, Theuns J, Van Broeckhoven C (2015) Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 31(3):140\u2013149. doi: 10.1016\/j.tig.2015.01.004","journal-title":"Trends Genet"},{"issue":"1","key":"1438_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J","volume":"30","author":"Y Wang","year":"1998","unstructured":"Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, Huser JM, Snow BJ, Ruth TJ, Calne DB (1998) Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 30(1):56\u201361. doi: 10.1002\/(sici)1098-2396(199809)30:1<56:aid-syn7>3.0.co;2-j","journal-title":"Synapse"},{"issue":"46","key":"1438_CR46","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102(46):16842\u201316847. doi: 10.1073\/pnas.0507360102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1438_CR47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","volume":"115","author":"W Xie","year":"2010","unstructured":"Xie W, Li X, Li C, Zhu W, Jankovic J, Le W (2010) Proteasome inhibition modeling nigral neuron degeneration in Parkinson\u2019s disease. J Neurochem 115(1):188\u2013199. doi: 10.1111\/j.1471-4159.2010.06914.x","journal-title":"J Neurochem"},{"key":"1438_CR48","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/S1353-8020(11)70058-X","volume":"18","author":"Q Xu","year":"2012","unstructured":"Xu Q, Shenoy S, Li C (2012) Mouse models for LRRK2 Parkinson\u2019s disease. Parkinsonism Relat Disord 18:S186\u2013S189. doi: 10.1016\/s1353-8020(11)70058-x","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"1438_CR49","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","volume":"21","author":"W Zhu","year":"2007","unstructured":"Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W (2007) Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J 21(14):3835\u20133844. doi: 10.1096\/fj.07-8386com","journal-title":"FASEB J"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-015-1438-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1438-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T04:37:18Z","timestamp":1567053438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-015-1438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,8]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1007\/s00702-015-1438-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,8]]}}}